News | TCTAP 2021 Virtual
News
News | TCTAP 2021 Virtual
Atherosclerotic Plaque Progression and Imaging
The 11th winner of TCTAP award ¡°Master of the Masters¡±
News | TCTAP 2021 Virtual
How Should Antithrombotic Strategies for CHIP and HBR Patients be tailored
Philip M. Urban, MD (Hopital de la Tour, Switzerland) addressed the prevalence of high bleeding risk (HBR) in patients of percutaneous coronary intervention (PCI) registries across multiple geographical regions at a session held during TCTAP 2021 Virtual.
News | TCTAP 2021 Virtual
iFR vs. FFR in Severe AS Patients: Which Is Better, and Is It Valid?
April 21th TCTAP Workshop Session of TCTAP 2021 Virtual
News | TCTAP 2021 Virtual
Percutaneous Treatment Considerations for Functional Mitral Regurgitation
Samir R. Kapadia, MD (Cleveland Clinic, Ohio, USA) discussed functional mitral regurgitation (MR) treatment considerations while sharing his experience with MitraClip Implant during a session at TCTAP 2021 Virtual that ran from April 21 to 24.
News | TCTAP 2021 Virtual
Chaos in Procedural MI (PMI) Definitions in PCI vs CABG Trials: How to Reconcile?
Patrick W. Serruys (NUI Galway, Ireland), examined the unresolved chaos regarding procedural MI (PMI) definition in PCI vs CABG trials during a session at TCTAP 2021 Virtual, suggesting possible upheaval of PMI definitions altogether.
News | COMPLEX PCI 2020 Virtual